Global Artificial Intelligence In Diagnostic Market Overview:
The presentation of AI platform is assessed to lift the clinical determination development by scaling up medical care administrations across the globe. It is projected to deliver improved patient safety, outcome scrutiny, and data assortment. Progressions in data analytics are considered to upsurge the growth in the healthcare artificial intelligence industry during the upcoming years. Artificial Intelligence In Diagnostic has the potential to transform medicinal diagnostics. In addition to detection of early illness and even the chance of prevention, it can improve the workflow of radiologists by stimulating delivery time and automatically prioritising urgent cases. An enormous amount of data is produced each year in the healthcare sector and ever-increasing volume of big data has created the requirement to implement artificial intelligence technology to handle this data resourcefully. Artificial intelligence has transformed the arena of healthcare by planning treatment plans, supporting monotonous tasks, drug discovery and medication supervision. It is likewise viably used for medical services information association by gathering, normalizing and storing data.
As per latest study released by AMA Research, the Global Artificial Intelligence In Diagnostic market is expected to see growth rate of 25.9%Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
The growing potential of AI-based tools for elderly care
Market Growth Drivers:
The influx of large and complex healthcare datasets, Growing need to reduce healthcare costs and Rising need for diagnostic costs reduction
Challenges:
Concerns regarding data privacy
Restraints:
Lack of skilled AI workforce and ambiguous regulatory guidelines and Reluctance of Medical Practitioners to Adopt AI-Based Technologies
Opportunities:
Rising need for improvised healthcare services due to imbalance between health workforce and patients
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Zebra Medical Vision Ltd (Israel), Riverain Technologies (United States), Siemens Healthineers AG (Germany), Neural Analytics, Inc. (Japan), IDx Technologies Inc. (United States), VUNO Inc (South Korea), Imagen Technologies, Inc.(United States), GE Healthcare (United States) and AliveCor, Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Artificial Intelligence In Diagnostic market by 2028. Considering Market by Technology, the sub-segment i.e. Machine Learning will boost the Artificial Intelligence In Diagnostic market. Considering Market by Diagnosis, the sub-segment i.e. Cardiology, will boost the Artificial Intelligence In Diagnostic market. Considering Market by Component, the sub-segment i.e. Software will boost the Artificial Intelligence In Diagnostic market. Considering Market by End User, the sub-segment i.e. Hospitals & Healthcare Providers will boost the Artificial Intelligence In Diagnostic market.
Latest Market Insights:
In 2020, Intel partnered with Maricopa County Community College District (MCCCD) to launch the first Intel-designed AI associate degree program in the US.
In April 2020 Israel-based Medtech startup Launched, AI Diagnostic Tool, for Frontline Doctors. Kahun’s new tool offers quick and easy access to information from thousands of published medical studies on the disease, using an algorithm that mimics the diagnosis process of physicians. The Kahun app has been designed to support the interpretation of text-based articles for clinical decision-making, placing a wealth of knowledge in the hands of physicians as they go about their duties
What Can be Explored with the Artificial Intelligence In Diagnostic Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Artificial Intelligence In Diagnostic Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Artificial Intelligence In Diagnostic
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Artificial Intelligence In Diagnostic market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Artificial Intelligence In Diagnostic market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Artificial Intelligence In Diagnostic Providers, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.